Results 31 to 33 of about 40 (33)

Transportability of nonlocal real-world evidence and its relevance to health technology assessment: a primer. [PDF]

J Comp Eff Res
Gupta A, Duffield S, Shephard C, Ting E, Popat S, Cheung WY, Arora P.   +6 more
europepmc   +1 more source

Improving practice in PD-L1 testing of non-small cell lung cancer in the UK: current problems and potential solutions. [PDF]

J Clin Pathol
Gosney JR, Peake MD, Kerr KM.
europepmc   +1 more source

Modelling Health State Utilities as a Transformation of Time to Death in Patients with Non-Small Cell Lung Cancer. [PDF]

Pharmacoeconomics
Hatswell AJ, Chaudhary MA, Monnickendam G, Moreno-Koehler A, Frampton K, Shaw JW, Penrod JR, Lawrance R.   +7 more
europepmc   +1 more source